MyBody-X angle on Sportgene Basis

MyBody-X's angle on 'Sportgene Basis' involves analyzing genetic variants linked to athletic performance, recovery, and injury risk. However, the scientific evidence supporting such tests is weak. While genes like COL1A1 (collagen) and MMP1 (tissue remodeling) have plausible mechanistic links to tendon health or skin integrity, effect sizes are small and heavily modulated by training, nutrition, and lifestyle. Most studies are observational or mechanistic, lacking clinical validation for direct use in training optimization or injury prevention. A single genetic test cannot reliably predict performance or injury risk. MyBody-X's provided context does not include robust clinical validation data for their sports genetics claims. Consumers should view these tests as curiosity-driven insights rather than actionable medical or athletic guidance. For improving sports performance, evidence-based strategies like progressive overload, proper recovery, and balanced nutrition remain far more impactful. Genetic testing may add a layer of interest but should not replace professional coaching or medical advice.